Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 2 | 3775 | 147 | 1.0466 | 0.9528 | 0.0389 | 0.0436 |
COLO 858 | Vemurafenib | I-BET151 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2385 | 147 | 0.5172 | 0.4925 | 0.0616 | 0.0680 |
WM-115 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1877 | 148 | 0.4133 | 0.4405 | 0.0788 | 0.0768 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 616 | 148 | 0.3584 | 0.4029 | 0.2403 | 0.2375 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 3 | 3001 | 148 | 0.2018 | 0.1959 | 0.0493 | 0.0416 |
A-375 | Vemurafenib | (+)-JQ1 | 0.316 | 0.000 | uM | 72 | hr | 2 | 4098 | 148 | 0.2793 | 0.2957 | 0.0361 | 0.0383 |
MZ7-mel | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 2302 | 149 | 0.4731 | 0.3676 | 0.0647 | 0.0695 |
A-375 | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 2 | 1440 | 149 | 0.0702 | 0.0695 | 0.1035 | 0.1086 |
MZ7-mel | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 2703 | 149 | 0.5612 | 0.6005 | 0.0551 | 0.0470 |
MZ7-mel | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 2225 | 149 | 0.4562 | 0.4826 | 0.0670 | 0.0734 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1605 | 149 | 0.4749 | 0.9734 | 0.0928 | 0.0805 |
A-375 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 5186 | 150 | 0.2413 | 0.2413 | 0.0289 | 0.0233 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 465 | 150 | 0.2413 | 0.2538 | 0.3226 | 0.3464 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 6306 | 150 | 0.3872 | 0.3831 | 0.0238 | 0.0229 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2574 | 151 | 0.7682 | 0.5584 | 0.0587 | 0.0586 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 3676 | 151 | 0.1689 | 0.1741 | 0.0411 | 0.0433 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 2545 | 151 | 0.4814 | 0.4188 | 0.0593 | 0.0678 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 859 | 151 | 0.5423 | 0.5371 | 0.1758 | 0.1786 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 3917 | 151 | 0.1971 | 0.1915 | 0.0385 | 0.0418 |
A-375 | Vemurafenib | Belinostat | 0.316 | 0.000 | uM | 72 | hr | 2 | 3734 | 151 | 0.2736 | 0.2662 | 0.0404 | 0.0401 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 2708 | 151 | 0.8340 | 0.7361 | 0.0558 | 0.0573 |
A-375 | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 1428 | 152 | 0.0694 | 0.0541 | 0.1064 | 0.1374 |
WM-115 | Vemurafenib | I-BET | 0.100 | 0.000 | uM | 72 | hr | 3 | 3445 | 152 | 0.9446 | 0.9015 | 0.0441 | 0.0495 |
A-375 | Vemurafenib | I-BET151 | 0.316 | 0.000 | uM | 72 | hr | 2 | 4409 | 152 | 0.3077 | 0.3027 | 0.0345 | 0.0319 |
WM-115 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1912 | 153 | 0.4204 | 0.4405 | 0.0800 | 0.0768 |